We live in an era of specialty pharmaceuticals -- drugs typically used to treat chronic, serious or life threatening conditions such as cancer, rheumatoid arthritis, growth hormone deficiency, and multiple sclerosis. Their cost is often much higher than
Read More...
Read the complete post at http://healthaffairs.org/blog/2014/09/23/health-affairs-briefing-specialty-pharmaceuticals-spending-and-policy/
Posted
Sep 23 2014, 01:12 PM
by
Health Affairs Blog